SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-207637
Filing Date
2013-05-08
Accepted
2013-05-08 16:38:27
Documents
1
Period of Report
2013-05-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d535631d8k.htm 8-K 14166
  Complete submission text file 0001193125-13-207637.txt   15443
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52062 | Film No.: 13825049
SIC: 2834 Pharmaceutical Preparations